DE60232443D1 - Polypeptid-destabiliserendes protein in zellen unter aeroben bedingungen und dieses codierende dna - Google Patents

Polypeptid-destabiliserendes protein in zellen unter aeroben bedingungen und dieses codierende dna

Info

Publication number
DE60232443D1
DE60232443D1 DE60232443T DE60232443T DE60232443D1 DE 60232443 D1 DE60232443 D1 DE 60232443D1 DE 60232443 T DE60232443 T DE 60232443T DE 60232443 T DE60232443 T DE 60232443T DE 60232443 D1 DE60232443 D1 DE 60232443D1
Authority
DE
Germany
Prior art keywords
cells
dna
protein
polypeptide
cells under
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60232443T
Other languages
English (en)
Inventor
Masahiro Hiraoka
Shinae Kondoh
Hiroshi Harada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oriental Yeast Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60232443D1 publication Critical patent/DE60232443D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4733Acute pancreatitis-associated protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60232443T 2001-06-05 2002-06-04 Polypeptid-destabiliserendes protein in zellen unter aeroben bedingungen und dieses codierende dna Expired - Lifetime DE60232443D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001169949 2001-06-05
JP2001169948 2001-06-05
PCT/JP2002/005482 WO2002099104A1 (fr) 2001-06-05 2002-06-04 Polypeptide destabilisant une proteine dans des cellules dans des conditions aerobies et adn codant pour ce polypeptide

Publications (1)

Publication Number Publication Date
DE60232443D1 true DE60232443D1 (de) 2009-07-09

Family

ID=26616379

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60232443T Expired - Lifetime DE60232443D1 (de) 2001-06-05 2002-06-04 Polypeptid-destabiliserendes protein in zellen unter aeroben bedingungen und dieses codierende dna

Country Status (8)

Country Link
US (1) US7700754B1 (de)
EP (1) EP1403365B1 (de)
JP (1) JP4130955B2 (de)
AT (1) ATE432346T1 (de)
AU (1) AU2002304163C1 (de)
CA (1) CA2449802C (de)
DE (1) DE60232443D1 (de)
WO (1) WO2002099104A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003208684A1 (en) * 2002-03-05 2003-09-16 Angiogenetics Sweden Ab Critical hypoxia-inducible factor-1alpha residues, products and methods related thereto
SI2264172T1 (sl) 2002-04-05 2017-12-29 Roche Innovation Center Copenhagen A/S Oligomerne spojine za modulacijo izražanja HIF-1alfa
KR101176245B1 (ko) 2004-11-09 2012-08-22 엔존 파마슈티컬즈, 인코포레이티드 HIF-1a 발현의 억제를 위한 효능적 LNA 올리고뉴클레오티드
US9447138B2 (en) 2004-11-09 2016-09-20 Roche Innovation Center Copenhagen A/S Potent LNA oligonucleotides for the inhibition of HIF-1a expression
EP1867716B1 (de) * 2005-03-11 2010-09-01 Nano Factory Co., Ltd. Tiermodell mit in echtzeit beobachtbarem krankheitszustand, genkonstrukt zur herstellung davon und verwendung davon
JP5186693B2 (ja) * 2008-01-16 2013-04-17 独立行政法人科学技術振興機構 低酸素状態にある細胞で増殖するウイルスまたは遺伝子を発現するウイルスベクター
EP2643459B1 (de) 2010-11-24 2017-09-27 Takara Bio USA, Inc. Transkriptionsmodulatoren mit einem system für induzierbare expression und einer domäne für verteilte proteintransduktion
US20120190107A1 (en) * 2011-01-26 2012-07-26 Dwayne Bisgrove Enhanced protein transduction
EP3929286A1 (de) * 2015-06-17 2021-12-29 Poseida Therapeutics, Inc. Zusammensetzungen und verfahren zur führung von proteinen an spezifische loci im genom
EP4215245A1 (de) * 2022-01-19 2023-07-26 Innovative Cellular Therapeutics Holdings, Ltd. Verbesserte chimäre antigenrezeptorzellen in einer hypoxischen tumormikroumgebung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804604A (en) 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
EP0656950B1 (de) 1992-08-21 1998-11-04 Biogen, Inc. Von tat abgeleitete transportpolypeptide
US5882914A (en) * 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1
WO1999010376A1 (en) 1997-08-22 1999-03-04 Washington University Inducible regulatory system and use thereof
GB9911047D0 (en) 1999-05-12 1999-07-14 Isis Innovation Assay method and means
US6485977B1 (en) * 1999-09-13 2002-11-26 Cornell Research Foundation, Inc. Recombinant constructs and techniques for delivering to eucaryotic cells bacterial proteins that are secreted via type III secretion systems

Also Published As

Publication number Publication date
ATE432346T1 (de) 2009-06-15
EP1403365B1 (de) 2009-05-27
EP1403365A1 (de) 2004-03-31
AU2002304163B2 (en) 2007-05-17
AU2002304163C1 (en) 2009-01-08
CA2449802C (en) 2012-02-07
AU2002304163B8 (en) 2002-12-16
JP4130955B2 (ja) 2008-08-13
JPWO2002099104A1 (ja) 2004-09-16
US7700754B1 (en) 2010-04-20
EP1403365A4 (de) 2005-01-19
CA2449802A1 (en) 2002-12-12
WO2002099104A1 (fr) 2002-12-12

Similar Documents

Publication Publication Date Title
DE3786321D1 (de) Expression von protein-c.
IL173399A0 (en) Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy
RU2007105677A (ru) Модифицированные витамин к-зависимые полипептиды
DE60232443D1 (de) Polypeptid-destabiliserendes protein in zellen unter aeroben bedingungen und dieses codierende dna
ATE105858T1 (de) Dna-moleküle, die für fmdh-kontrollabschnitte und strukturgene für ein protein mit fmdh-aktivität kodieren, sowie deren anwendung.
WO2002031134A3 (en) Novel serine protease genes related to dppiv
FI102539B1 (fi) Nitriilihydrataasiaktiivisuutta omaavaa polypeptidiä koodaava DNA-fragmentti, geenin sisältävä transformantti ja menetelmä amidien tuottamiseksi transformanttia käyttäen
AR023482A1 (es) Acidos nucleicos que codifican polipeptidos quimericos cd40/cd4ol, metodos para su produccion y usos de los mismos
ATE93272T1 (de) Expression von protein c.
Takeyama et al. Fo portion of Escherichia coli H+-ATPase. Carboxyl-terminal region of the b subunit is essential for assembly of functional Fo.
JP2002511262A5 (de)
HUP0302240A2 (hu) Humán receptorfehérjék, ezekkel kapcsolatos reagensek és eljárások
EP0111814A3 (de) Klonierung und Expression von nucleotiden Sequenzen die für Rinderwachstumshormon kodieren
JPS6420095A (en) Polypeptide having anti-blood coagulating action
ES2059854T3 (es) Nuevo polipeptido y su produccion.
DE69431068D1 (de) Das polypeptid eines membran-proteins mit der funktion zur unterstützung des wachstums von prä-b zellen und sein gen
DE69433902D1 (de) Neuartige tyrosinkinase
HUP0102758A2 (hu) Angiosztatin-kötő protein
CN1159206A (zh) 由酵母生产和分泌重组血纤维蛋白原
Hara et al. Expression of active alpha-3 subunit of rat brain Na+, K+-ATPase from the messenger RNA injected into Xenopus oocytes
Roof et al. Magnesium transport systems: genetics and protein structure (a review).
WO2003057827A3 (en) Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes
ATE181115T1 (de) Stabilisierung von messenger-rns in tierischen zellen
DE59914878D1 (de) Neuer spannungsabhängiger kaliumkanal und seine verwendung zur entwicklung von therapeutika
WO1999027094A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NANO FACTORY CO., LTD., KYOTO, JP

R081 Change of applicant/patentee

Ref document number: 1403365

Country of ref document: EP

Owner name: ORIENTAL YEAST CO. LTD., JP

Free format text: FORMER OWNER: NANO FACTORY CO., LTD., KYOTO, JP

Effective date: 20110620

R082 Change of representative

Ref document number: 1403365

Country of ref document: EP

Representative=s name: ULLRICH & NAUMANN, 69115 HEIDELBERG, DE